Liran Nsimi - Sano Brunos Deputy CEO
SANO1 Stock | 36,140 100.00 0.28% |
Insider
Liran Nsimi is Deputy CEO of Sano Brunos Enterprises
Age | 46 |
Phone | 972 9 747 3222 |
Web | https://www.sano.co.il |
Sano Brunos Management Efficiency
The company has return on total asset (ROA) of 0.0592 % which means that it generated a profit of $0.0592 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1077 %, meaning that it generated $0.1077 on every $100 dollars invested by stockholders. Sano Brunos' management efficiency ratios could be used to measure how well Sano Brunos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Ofir Attias | Rami Levi | 46 | |
Daniella Finn | Strauss Group | N/A | |
Yoram Cohen | Al Bad Massuot Yitzhak | 58 | |
Yafit Atias | Rami Levi | 40 | |
Advocate Adv | Strauss Group | 55 | |
Hila Mukevisius | Strauss Group | 49 | |
Rami Levy | Rami Levi | 68 | |
Nahum Levavi | Al Bad Massuot Yitzhak | 49 | |
Hanan Adler | Al Bad Massuot Yitzhak | 48 | |
Shai Babad | Strauss Group | N/A | |
SaydoffBarashi Inbal | Rami Levi | 46 | |
Gadi Choresh | Al Bad Massuot Yitzhak | N/A | |
Wolfgang Tenbusch | Al Bad Massuot Yitzhak | 69 | |
Adam Friedler | Rami Levi | N/A | |
Roman Litronic | Al Bad Massuot Yitzhak | 46 | |
Yossi Kahane | Neto ME Holdings | N/A | |
Shmulik Levy | Rami Levi | 61 | |
Osnat Golan | Strauss Group | N/A | |
Sandler Ohad | Rami Levi | N/A | |
Esti Carmeli | Strauss Group | N/A | |
Eyal Dror | Strauss Group | 53 |
Management Performance
Return On Equity | 0.11 | |||
Return On Asset | 0.0592 |
Sano Brunos Enterprises Leadership Team
Elected by the shareholders, the Sano Brunos' board of directors comprises two types of representatives: Sano Brunos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sano. The board's role is to monitor Sano Brunos' management team and ensure that shareholders' interests are well served. Sano Brunos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sano Brunos' outside directors are responsible for providing unbiased perspectives on the board's policies.
Yuval Landesberg, Chief Officer | ||
Amir Horovitz, General Counsel, Secretary | ||
Barak CPA, CFO Controller | ||
Ehud Erlich, VP of HR and Admin. | ||
Joseph Zamnabda, Chief Officer | ||
Dalit BrandLevine, Vice President - Business Development | ||
Mike Freeman, ViceChairman Systems | ||
Liran Nsimi, Deputy CEO |
Sano Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sano Brunos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.11 | |||
Return On Asset | 0.0592 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.10 % | |||
Current Valuation | 2.09 B | |||
Shares Outstanding | 11.24 M | |||
Shares Owned By Insiders | 77.48 % | |||
Shares Owned By Institutions | 0.03 % | |||
Price To Book | 1.61 X | |||
Price To Sales | 1.45 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sano Stock Analysis
When running Sano Brunos' price analysis, check to measure Sano Brunos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sano Brunos is operating at the current time. Most of Sano Brunos' value examination focuses on studying past and present price action to predict the probability of Sano Brunos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sano Brunos' price. Additionally, you may evaluate how the addition of Sano Brunos to your portfolios can decrease your overall portfolio volatility.